Cost-Effectiveness of Empagliflozin In Patients With Type 2 Diabetes Mellitus At High Cardiovascular Risk In Poland
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.453
https://www.valueinhealthjournal.com/article/S1098-3015(17)30787-8/fulltext
Title :
Cost-Effectiveness of Empagliflozin In Patients With Type 2 Diabetes Mellitus At High Cardiovascular Risk In Poland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30787-8&doi=10.1016/j.jval.2017.08.453
First page :
A478
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
428